Tranexamic Acid Dosing Considerations

Introduction to Dosing Adjustments

• The American Thoracic Society recommends maintaining the dose per administration at 10-15 mg/kg to preserve the concentration-dependent bactericidal effect, but reducing the frequency rather than the individual dose in patients with renal impairment 1

Age-Specific Dosing

• The European Society of Cardiology suggests that elderly patients have higher serum levels and prolonged drug exposure compared to younger patients, and age-related decline in creatinine clearance occurs even with normal serum creatinine 2
• The American College of Cardiology recommends reducing the maximum dose to 10 mg/kg per day (750 mg maximum) for patients over 59 years of age due to age-related decline in renal function 1

Clinical Context-Specific Dosing

• The American Society of Anesthesiologists recommends a standard regimen of 1 g IV over 10 minutes within 3 hours of injury, followed by 1 g infusion over 8 hours for major trauma/hemorrhage, but a 2 g single bolus over 20 minutes may be equally effective and simpler to administer 5

Monitoring Requirements

• The European Society of Cardiology recommends baseline and periodic renal function monitoring (serum creatinine, creatinine clearance) and maintaining adequate diuresis in elderly and renally impaired patients receiving TXA 6
• The American Heart Association recommends avoiding TXA in patients on hemodialysis until after dialysis to facilitate directly observed therapy and prevent premature drug removal 1

Critical Contraindications

• The American College of Chest Physicians states that TXA is absolutely contraindicated in active intravascular clotting or disseminated intravascular coagulation, and massive hematuria (risk of ureteric obstruction from clot retention) 7